226 related articles for article (PubMed ID: 23856182)
1. [Advanced Parkinson's disease: clinical characteristics and treatment (part 1)].
Kulisevsky J; Luquin MR; Arbelo JM; Burguera JA; Carrillo F; Castro A; Chacón J; García-Ruiz PJ; Lezcano E; Mir P; Martinez-Castrillo JC; Martínez-Torres I; Puente V; Sesar A; Valldeoriola-Serra F; Yañez R
Neurologia; 2013 Oct; 28(8):503-21. PubMed ID: 23856182
[TBL] [Abstract][Full Text] [Related]
2. Advanced Parkinson's disease: clinical characteristics and treatment. Part II.
Kulisevsky J; Luquin MR; Arbelo JM; Burguera JA; Carrillo F; Castro A; Chacón J; García-Ruiz PJ; Lezcano E; Mir P; Martinez-Castrillo JC; Martínez-Torres I; Puente V; Sesar A; Valldeoriola-Serra F; Yañez R
Neurologia; 2013; 28(9):558-83. PubMed ID: 23880230
[TBL] [Abstract][Full Text] [Related]
3. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
Annic A; Devos D; Seguy D; Dujardin K; Destée A; Defebvre L
Rev Neurol (Paris); 2009; 165(8-9):718-27. PubMed ID: 19150100
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
[TBL] [Abstract][Full Text] [Related]
5. Neurostimulation for Parkinson's disease with early motor complications.
Schuepbach WM; Rau J; Knudsen K; Volkmann J; Krack P; Timmermann L; Hälbig TD; Hesekamp H; Navarro SM; Meier N; Falk D; Mehdorn M; Paschen S; Maarouf M; Barbe MT; Fink GR; Kupsch A; Gruber D; Schneider GH; Seigneuret E; Kistner A; Chaynes P; Ory-Magne F; Brefel Courbon C; Vesper J; Schnitzler A; Wojtecki L; Houeto JL; Bataille B; Maltête D; Damier P; Raoul S; Sixel-Doering F; Hellwig D; Gharabaghi A; Krüger R; Pinsker MO; Amtage F; Régis JM; Witjas T; Thobois S; Mertens P; Kloss M; Hartmann A; Oertel WH; Post B; Speelman H; Agid Y; Schade-Brittinger C; Deuschl G;
N Engl J Med; 2013 Feb; 368(7):610-22. PubMed ID: 23406026
[TBL] [Abstract][Full Text] [Related]
6. Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study.
Pintor LP; Valldeoriola F; Fernández-Egea E; Sánchez R; Rami L; Tolosa E; Muñiz A; Martí MJ; Bernardo M
J ECT; 2012 Jun; 28(2):87-91. PubMed ID: 22531200
[TBL] [Abstract][Full Text] [Related]
7. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Yamada K; Goto S; Hamasaki T; Kuratsu JI
Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
[TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced Parkinson's disease.
Diamond A; Jankovic J
Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
[TBL] [Abstract][Full Text] [Related]
9. [Levodopa in the treatment of Parkinson's disease: myths and realties].
Luquin MR; García-Ruiz PJ; Martí MJ; Rojo A; Vela L; Grandas FJ; Bravo-Utrera M; Burguera JA; Chacón JR; Campos-Arillo VM; Durán-Herrera C; Fernández-García JM; García-Ramos R; Gómez-Esteban JC; Gutierrez J; Juni J; Mata M; Martínez-Castrillo JC; Olivares J; Ribacoba-Montero R; Santos-García D; Sierra M; Valero-Merino C
Rev Neurol; 2012 Dec; 55(11):669-88. PubMed ID: 23172094
[TBL] [Abstract][Full Text] [Related]
10. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
[TBL] [Abstract][Full Text] [Related]
11. Motor complications in Parkinson's disease: ten year follow-up study.
López IC; Ruiz PJ; Del Pozo SV; Bernardos VS
Mov Disord; 2010 Dec; 25(16):2735-9. PubMed ID: 20931632
[TBL] [Abstract][Full Text] [Related]
12. Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications.
Solla P; Cannas A; Floris GL; Orofino G; Costantino E; Boi A; Serra C; Marrosu MG; Marrosu F
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1009-13. PubMed ID: 21324349
[TBL] [Abstract][Full Text] [Related]
13. Motor complications in Parkinson disease: clinical manifestations and management.
Bhidayasiri R; Truong DD
J Neurol Sci; 2008 Mar; 266(1-2):204-15. PubMed ID: 17897677
[TBL] [Abstract][Full Text] [Related]
14. Levodopa-related motor complications--phenomenology.
Fox SH; Lang AE
Mov Disord; 2008; 23 Suppl 3():S509-14. PubMed ID: 18781677
[TBL] [Abstract][Full Text] [Related]
15. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.
Devos D;
Mov Disord; 2009 May; 24(7):993-1000. PubMed ID: 19253412
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.
Marras C; Lang A; Krahn M; Tomlinson G; Naglie G;
Mov Disord; 2004 Jan; 19(1):22-8. PubMed ID: 14743356
[TBL] [Abstract][Full Text] [Related]
17. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M
J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256
[TBL] [Abstract][Full Text] [Related]
18. What factors influence motor complications in Parkinson disease?: a 10-year prospective study.
García-Ruiz PJ; Del Val J; Fernández IM; Herranz A
Clin Neuropharmacol; 2012; 35(1):1-5. PubMed ID: 22139623
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries.
Hechtner MC; Vogt T; Zöllner Y; Schröder S; Sauer JB; Binder H; Singer S; Mikolajczyk R
Parkinsonism Relat Disord; 2014 Sep; 20(9):969-74. PubMed ID: 24953743
[TBL] [Abstract][Full Text] [Related]
20. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
